Edition:
United States

Biogaia AB (BIOGb.ST)

BIOGb.ST on Stockholm Stock Exchange

240.00SEK
27 Jul 2016
Change (% chg)

-- (--)
Prev Close
240.00kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,967
52-wk High
315.50kr
52-wk Low
197.00kr

BIOGb.ST

Chart for BIOGb.ST

About

Biogaia AB is a Sweden-based company engaged in the development and sell of probiotic products, primarily based on the Lactobacillus reuteri bacteria. The Company’s activities are divided into three segments: Finished consumer products, which distributes tablets, drops, Oral Rehydration Solutions (ORSs), and oral health... (more)

Overall

Beta: 0.82
Market Cap(Mil.): kr3,933.20
Shares Outstanding(Mil.): 16.60
Dividend: 3.03
Yield (%): 2.11

Financials

  BIOGb.ST Industry Sector
P/E (TTM): 36.64 28.44 46.77
EPS (TTM): 6.47 -- --
ROI: 29.04 10.32 50.27
ROE: 29.16 13.79 56.13

BRIEF-Biogaia says rights issue in former subsidiary IBT fully subscribed

* Says rights issue in IBT fully subscribed - Biogaia's underwriting guarantee will not be utilized

May 26 2016

BRIEF-Biogaia posts positive result in probiotics study, confirms earlier result

* Biogaia's probiotic effective in treating abdominal pain in children

May 17 2016

BRIEF-Swedish pension fund increases Biogaia stake

* Swedish pension fund Fjarde AP-fonden increases stake to 5.44 percent of shares, 3.93 percent of votes - FSA filing

Feb 23 2016

BRIEF-BioGaia Q4 op profit fell to 28 mln SEK

* Says board proposes that upcoming annual general meeting on 10 may 2016 approve an ordinary dividend of SEK 3.03 per share and an extraordinary dividend of SEK 1.97 per share, for a total dividend of SEK 5.00 per share. Link to report: http://mb.cision.com/Main/3271/9913101/476241.pdf Further company coverage:

Feb 12 2016

BRIEF-Biogaia: to distribute and list IBT subsidiary

* Says proposes distribution and separate listing of Infant Bacterial Therapeutics (IBT) subsidiary

Feb 12 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.